Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Boehringer Ingelheim
Welcome,
Profile
Billing
Logout
127 Products
608 Diseases
127 Products
564 Trials
30435 News
1
2
3
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
42
84
126
168
210
252
294
336
378
420
Jardiance
(empagliflozin) / Eli Lilly, Boehringer Ingelheim
Gilotrif
(afatinib) / Boehringer Ingelheim
Activase
(alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Tradjenta
(linagliptin) / Boehringer Ingelheim, Eli Lilly
TNKASE
(tenecteplase) / Roche, Boehringer Ingelheim
Skyrizi
(risankizumab-rzaa) / AbbVie, Boehringer Ingelheim
Aptivus
(tipranavir) / Boehringer Ingelheim
Stiolto Respimat
(olodaterol/tiotropium FDC) / Boehringer Ingelheim
faldaprevir
(BI201335) / Boehringer Ingelheim
Striverdi Respimat
(olodaterol) / Boehringer Ingelheim
Synjardy
(empagliflozin/metformin) / Boehringer Ingelheim, Eli Lilly
Spiriva Respimat
(tiotropium bromide) / Boehringer Ingelheim
Spevigo
(spesolimab-sbzo) / Boehringer Ingelheim
ezabenlimab
(BI 754091) / Boehringer Ingelheim
Combivent
(ipratropium/salbutamol) / Boehringer Ingelheim
iclepertin
(BI425809) / Boehringer Ingelheim
Jentadueto
(linagliptin/metformin) / Eli Lilly, Boehringer Ingelheim
volasertib
(NBL-001) / Oncoheroes, Notable Labs
osoresnontrine
(BI 409306) / Boehringer Ingelheim
survodutide
(BI 456906) / Zealand Pharma, Boehringer Ingelheim
nerandomilast
(BI 1015550) / Boehringer Ingelheim
Basaglar
(insulin glargine biosimilar) / Boehringer Ingelheim, Eli Lilly
deleobuvir
(BI 207127) / Boehringer Ingelheim
BI 1358894
/ Boehringer Ingelheim
Berodual N
(ipratropium bromide/fenoterol hydrobromide) / Boehringer Ingelheim
BI 730357
/ Boehringer Ingelheim
avenciguat
(BI 685509) / Boehringer Ingelheim
Praxbind
(idarucizumab) / Boehringer Ingelheim
Alesion
(epinastine) / Boehringer Ingelheim
ifebemtinib
(IN10018) / InxMed
BI 1291583
/ Boehringer Ingelheim
BI 54903
/ Boehringer Ingelheim
BI2536
/ Boehringer Ingelheim
Cyltezo
(adalimumab-adbm) / Boehringer Ingelheim
ritobegron
(KUC 7483) / Boehringer Ingelheim
BEA 2180 BR
/ Boehringer Ingelheim
BI 836880
/ Boehringer Ingelheim
Glyxambi
(empagliflozin / linagliptin) / Boehringer Ingelheim, Eli Lilly
Lendormin
(brotizolam) / Boehringer Ingelheim
brigimadlin
(BI 907828) / Boehringer Ingelheim
BI 1026706
/ Boehringer Ingelheim
BI 671800 ED
/ Boehringer Ingelheim
xentuzumab
(BI-836845) / Boehringer Ingelheim
zongertinib
(BI 1810631) / Boehringer Ingelheim
BI 690517
/ Boehringer Ingelheim
BI 764198
/ Boehringer Ingelheim
BI 764532
/ Boehringer Ingelheim
BI-44370 TA
/ Boehringer Ingelheim
BI 1323495
/ Boehringer Ingelheim
BI 655064
/ AbbVie, Boehringer Ingelheim
1
2
3
»
